Medtronic and davita announce new kidney health technology company

Companies join forces to accelerate kidney care device innovation and improve patient outcomes dublin and denver, may 26, 2022 /prnewswire/ -- medtronic plc (nyse:mdt) and davita inc. (nyse:dva) today announced the intent to form a new, independent kidney care-focused medical device company ("newco" or "the company") to enhance the patient treatment experience and improve overall outcomes. by bringing together medtronic's capabilities as a healthcare technology leader and davita's deep expertise as a comprehensive kidney care provider, newco will be uniquely positioned to advance the development of differentiated therapies for patients with kidney failure.
DVA Ratings Summary
DVA Quant Ranking